BriaCell Therapeutics Corp. (BCT.TO)
Develops immunotherapy treatments to train the immune system to fight cancer.
4.86+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-52.8%
The outlook
BCT.TO is trading near its 52-week lows, sitting just 7% above the bottom of its yearly range. The stock shows mixed positioning relative to its moving averages, and analyst coverage leans bearish overall. Current price sits flat today at $4.86.
What’s behind the score
Price trendMixed vs its moving averages
52-week range7% of the way from its 52-week low to high
Market cap
$42.3M
52-wk high
20.40
52-wk low
3.68
50-day avg
4.70
200-day avg
8.10
Trailing P/E
—